FDA Inspection 745871 — OneBlood, Inc.
The FDA completed an inspection of OneBlood, Inc. on Dec 19, 2011 in Fort Lauderdale, FL. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 10 citations were issued during this inspection. Product area: Biologics.
Inspection details
- Classification
- Official Action Indicated (OAI)
- End Date
- Dec 19, 2011
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fort Lauderdale, FL (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 142 | 21 CFR 606.140(a) | Establishment of spec., standards, and test procedures |
| 154 | 21 CFR 606.160(a)(1) | Concurrent documentation |
| 159 | 21 CFR 606.160(a)(1) | Legibility and indelibility |
| 160 | 21 CFR 606.160(a)(1) | Person performing, test results, interpretation |
| 31 | 21 CFR 606.20(b) | Qualifications of responsible personnel |
| 76 | 21 CFR 606.100(b) | Establish, maintain and follow manufacturing SOPs |
| 78 | 21 CFR 606.100(c) | Record review prior to release |
| 9225 | 21 CFR 606.171 | Biological product deviation report |
| 9234 | 21 CFR 630.40(c) | Notification w/in 8 weeks |
| 98 | 21 CFR 606.100(c) | Thorough investigations |
Need the full FDA record for OneBlood, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.